How much has Intuitive Surgical raised?
Intuitive Surgical is not venture-backed. As of June 2026 it was a public company trading as Nasdaq: ISRG, with an approximate ~$200B market capitalization and $10.1B of 2025 revenue.
- Public status
- Nasdaq: ISRG
- Market cap
- ~$200B (Jun 2026)
- Revenue
- $10.1B 2025
- Funding type
- Public markets
- First raised
- Not VC disclosed
- Seller signal
- Enterprise healthcare buyer
Intuitive Surgical's capital history
Intuitive Surgical's capital history is public-company funding, operating cash flow, acquisitions, and market access rather than startup rounds.
- 1995Company foundedIntuitive Surgical begins the business that later scales into a public healthcare company.
- Public listingNasdaq: ISRG public-market accessPublic equity and debt-market access replace startup-style venture rounds as the relevant capital lens.
- M&A eraPortfolio expansionAcquisitions, divestitures, and internal reinvestment become important capital-allocation tools.
- 2025$10.1B revenueIntuitive Surgical reports $10.1B of revenue for 2025.
- Jun 2026~$200B market capIntuitive Surgical trades as Nasdaq: ISRG with large public-market buying capacity.
Sources:Intuitive Surgical annual reportsNasdaq: ISRG market data
How much has Intuitive Surgical raised in total?
Intuitive Surgical does not have a meaningful disclosed venture-funding total. The company should be evaluated through public equity, operating cash flow, debt capacity, acquisitions, divestitures, and retained earnings rather than Seed, Series A, or late-stage venture rounds.
Who are Intuitive Surgical's investors?
The relevant investors are public-market shareholders, bondholders where applicable, index funds, active healthcare investors, and strategic capital allocators inside the company. Their focus is durable revenue, margins, cash conversion, regulatory risk, reimbursement exposure, and management's ability to deploy capital at attractive returns.
Why does Intuitive Surgical's valuation move?
Intuitive Surgical's valuation moves with growth, margins, cash flow, reimbursement or pricing pressure, regulatory developments, product cycles, acquisition execution, labor and supply costs, and investor confidence in management's outlook. Healthcare buyers can still spend during turbulent markets, but approvals become more tied to measurable savings and risk control.
Is Intuitive Surgical profitable, and will it IPO?
Intuitive Surgical is already public. Profitability should be assessed from its filings and earnings releases rather than IPO readiness; the practical question is how much cash and management attention can be allocated to new vendors, systems, facilities, clinical programs, or commercial expansion.
What does Intuitive Surgical's funding mean if you sell into them?
The company has enterprise-scale budget capacity, but procurement is mature and evidence-driven. Sellers should expect security review, compliance review, legal negotiation, business-unit sponsorship, and a requirement to prove value in patient outcomes, operating efficiency, revenue capture, supply reliability, or risk reduction.
As of June 2026.Sources:Intuitive Surgical resultsIntuitive Surgical annual reportsNasdaq: ISRG market data
Intuitive Surgical — frequently asked questions
